Ji, S., Lin, W., Wang, L., Ni, Z., Jin, F., Zha, X., & Fei, G. (2017). Combined Targeting of mTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex. J Cancer.
Čikaški stil citiranjaJi, Shuang, Wei Lin, Li Wang, Zhaofei Ni, Fuquan Jin, Xiaojun Zha, i Guanghe Fei. "Combined Targeting of MTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex." J Cancer 2017.
MLA način citiranjaJi, Shuang, et al. "Combined Targeting of MTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex." J Cancer 2017.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.